Approves

FDA Approves Orladeyo

FDA Approves Orladeyo

FDA Approves Orladeyo (berotralstat) as the First Oral, Once-Daily Therapy to Prevent Attacks in Hereditary

FDA Approves Jatenzo

FDA Approves Jatenzo

March 27, 2019 — The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate),